| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 44 |
| 1 | METHOTREXATE SODIUM | 22 |
| 2 | PREDNISONE | 22 |
| 3 | ESOMEPRAZOLE MAGNESIUM | 17 |
| 4 | METHOTREXATE | 16 |
| 5 | ALBUTEROL SULFATE | 15 |
| 6 | OMEPRAZOLE MAGNESIUM | 15 |
| 7 | ETANERCEPT | 14 |
| 8 | ASPIRIN | 13 |
| 9 | ERGOCALCIFEROL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HELIOX | 1 | 0.0256 |
| 1 | PORFIMER SODIUM | 2 | 0.0059 |
| 2 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 3 | PROPAFENONE | 4 | 0.0009 |
| 4 | CLINDAMYCIN PHOSPHATE | 5 | 0.0009 |
| 5 | DACTINOMYCIN | 2 | 0.0009 |
| 6 | AMIVANTAMAB-VMJW | 3 | 0.0008 |
| 7 | NATEGLINIDE | 1 | 0.0007 |
| 8 | PSYLLIUM HUSK | 1 | 0.0007 |
| 9 | THIOTEPA | 7 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 43 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 3 | Proton Pump Inhibitor [EPC] | 19 |
| 4 | Benzodiazepine [EPC] | 17 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 7 | Provitamin D2 Compound [EPC] | 12 |
| 8 | GLP-1 Receptor Agonist [EPC] | 11 |
| 9 | Vitamin C [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Actinomycin [EPC] | 2 | 0.0009 |
| 2 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 4 | Thymic Stromal Lymphopoietin Blocker [EPC] | 2 | 0.0003 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |